Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vitamin B12 transporters are a specialized group of proteins, including Gastric intrinsic factor (GIF), Cubilin (CUBN), and the Transcobalamin receptor (CD320), which collectively manage the absorption and cellular entry of cobalamin (Vitamin B12). In the gastrointestinal tract, B12 binds to GIF and is recognized by the Cubilin-Amnionless complex in the ileum for internalization (PMID: 11134015). Once in the bloodstream, B12 is carried by Transcobalamin II (TCN2) and enters peripheral cells via CD320-mediated endocytosis (PMID: 18779389). These transporters are significant therapeutic targets because they can be leveraged for the oral delivery of large molecules, such as insulin or GLP-1 analogs, by conjugating them to B12 to exploit the natural uptake pathway (PMID: 22403342). Furthermore, the overexpression of CD320 in various malignancies makes it a candidate for targeted delivery of cytotoxic agents and radiopharmaceuticals (PMID: 25130395). Dysfunctions in these transporters are linked to clinical conditions such as megaloblastic anemia and various neurodegenerative symptoms due to impaired DNA synthesis and myelin maintenance (StatPearls: NBK441923). The system's high specificity and efficiency in transporting cobalamin make it an attractive platform for overcoming biological barriers in drug development.
Facilitation of Vitamin B12 (cobalamin) absorption and cellular entry through high-affinity binding and receptor-mediated endocytosis.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vitamin B12 transporters (B12T).